175 followers
Study investigates bayesian-guided dosing; a new dosing tool aims to reduce exposure variability to infliximab in patients with inflammatory diseases. Read more…
Study investigates bayesian-guided dosing; a new dosing tool aims to reduce exposure variability to infliximab in patients with inflammatory diseases. Read more…
RT @AAPSComms: #AAPSJ PRECISION MEDICINE THEME: "Dashboards for Therapeutic Monoclonal Antibodies: Learning and Confirming" https://t.co/Qv…
#AAPSJ PRECISION MEDICINE THEME: "Dashboards for Therapeutic Monoclonal Antibodies: Learning and Confirming" https://t.co/QvzTkuduay https://t.co/IE27cu1fHu